Skip to main content
. 2024 Nov 20;7(11):e2446336. doi: 10.1001/jamanetworkopen.2024.46336

Figure 1. Study Design and Directions of Drug Class Switching.

Figure 1.

JAKi indicates Janus kinase inhibitor; TNFi, tumor necrosis factor inhibitor.